Role of hysteroscopy during conservative management of atypical endometrial hyperplasia and early-stage endometrial cancer in patients who desire pregnancy

J Obstet Gynaecol. 2022 Nov;42(8):3435-3440. doi: 10.1080/01443615.2022.2152656.

Abstract

Twenty-five percent of cases of endometrial cancer appear in women with unfulfilled reproductive desires. An adequate selection of patients and a close hysteroscopic follow-up to monitor the endometrial response to the levonorgestrel-releasing intrauterine system (LNG-IUS) may be a valid and safe option for these patients. This is a case series and review of the literature study. We included eight patients diagnosed of complex endometrial hyperplasia with atypia (CEHA) or stage 1AG1 well-differentiated endometrial cancer without myometrial invasion who desired to get pregnant and opted for a conservative treatment. Follow-up was performed with hysteroscopy and directed biopsy at 3, 6 and 12 months. Of the 854 cases of complex endometrial hyperplasia with atypia (CEHA)/endometrial cancer were diagnosed, 2.3% were candidates for conservative management. We obtained a favourable regression of 71.2% at 6 months and 57% at one year with hormonal treatment. Conservative treatment in complex endometrial hyperplasia with atypia (CEHA)/low-grade endometrial cancer in reproductive age patients with a strong desire for pregnancy is feasible.

Keywords: LNG-IUS; Low-grade endometrial cancer; atypia; complex endometrial hyperplasia; fertility; hysteroscopy.

Publication types

  • Review

MeSH terms

  • Conservative Treatment
  • Contraceptive Agents, Female*
  • Endometrial Hyperplasia* / drug therapy
  • Endometrial Hyperplasia* / pathology
  • Endometrial Neoplasms* / pathology
  • Endometrial Neoplasms* / therapy
  • Female
  • Humans
  • Hysteroscopy
  • Intrauterine Devices, Medicated*
  • Levonorgestrel / therapeutic use
  • Pregnancy

Substances

  • Levonorgestrel
  • Contraceptive Agents, Female